InvestorNewsBreaks

Thursday Aug 08, 2024 - 9:47 am

InvestorNewsBreaks — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Releases Q2, H1 2024 Financial Results Report

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting on its second-quarter and half-year 2024 results for the period ended June 30, 2024. The report showed stronger financial results, improved liquidity and capital resource, and steady gold and silver production. The company will be hosting a conference call and webcast today to discuss…

Thursday Aug 08, 2024 - 9:38 am

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Now Trading on Frankfurt Stock Exchange

Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor, through its JustCBD brand, is now trading its common shares on the Frankfurt Stock Exchange ("FSE") under the symbol 7301. According to the announcement, the FSE is the world’s third largest stock organized exchange-trading market, behind U.S.-based NASDAQ and the New York Stock Exchange (“NYSE”), based on terms of turnover and dealings with securities.…

Thursday Aug 08, 2024 - 9:29 am

InvestorNewsBreaks – Exro Technologies Inc.’s (TSX: EXRO) (OTCQB: EXROF) Execs to Participate at This Month’s Canaccord Genuity 44th Annual Growth Conference

Exro Technologies (TSX: EXRO) (OTCQB: EXROF), a leading clean-technology company that provides proprietary motor-control and complete electric propulsion system technology for e-mobility, will be participating in the upcoming Canaccord Genuity 44th Annual Growth Conference. According to the announcement, the event will be held Aug. 13–15, 2024, in Boston. During the three-day conference, Exro CEO Sue Ozdemir and CFO Darrell Bishop are slated to lead a group…

Thursday Aug 08, 2024 - 9:15 am

InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Reports Concussion Drug Passes FDA-Required Cardiotoxicity Testing

Oragenics (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, is reporting that ONP-002, its lead candidate for treating concussion, has successfully completed a study indicating the substance does not cause cardiotoxicity. Testing pharmaceuticals on cardiac receptors to ensure that they do not show any causes of electrical malformations is required by the U.S. Food and Drug…

Wednesday Aug 07, 2024 - 3:16 pm

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Subsidiary Submits Proposal to CDMRP for Ovarian Cancer Detection Research Award

Aditxt (NASDAQ: ADTX), a company dedicated to discovering, developing and deploying promising health innovations, and its subsidiary, Pearsanta Inc., has submitted a proposal for the Clinical Trial Translational Endpoints Research Award to the Congressionally Directed Medical Research Programs (“CDMRP”) of the Department of Defense. According to the announcement, the proposal is designed to validate a novel assay based on Pearsanta’s proprietary Mitomic(R) technology designed for the…

Wednesday Aug 07, 2024 - 3:07 pm

InvestorNewsBreaks – Pineapple Financial Inc. (NYSE American: PAPL) Spotlighted in RazorPitch Article Highlighting Tremendous Growth Opportunities in Canada’s Unique Mortgage Market

Pineapple Financial (NYSE American: PAPL), a digital mortgage company focused on providing Canadian mortgage brokers with the systems, tools, and technologies they need to provide home buyers and mortgage seekers with a more digital customer experience, has been featured in a RazorPitch article. With Canada’s unique mortgage market requiring holders to refinance after every five years, Pineapple Financial offers investors the perfect way to capitalize…

Wednesday Aug 07, 2024 - 2:59 pm

InvestorNewsBreaks – Match Group Inc. (NASDAQ: MTCH) Quarterly Earnings Report Highlights

Match Group (NASDAQ: MTCH), a leading company in the internet commerce industry, recently reported its quarterly earnings, aligning with the Zacks Consensus Estimate at $0.48 per share, mirroring its performance from the previous year. The company’s revenue for the quarter ending June 2024 was $864.07 million, slightly up from the previous year’s $829.55 million, and exceeded the Zacks Consensus Estimate by 0.92%. This achievement marks the fourth…

Wednesday Aug 07, 2024 - 2:50 pm

InvestorNewsBreaks – Scorpius Holdings Inc. (NYSE American: SCPX) Releases Public Offering Pricing for Public Offering

Scorpius Holdings (NYSE American: SCPX), an integrated contract-development and manufacturing organization (CDMO), has announced the pricing of an underwritten public offering. The offering is comprised of 12,500,000 shares of common stock or prefunded warrants. Each share of common stock or prefunded warrant is offered at $1. According to the announcement, the company has estimated gross proceeds of approximately $12,500,000, before underwriting discounts and offering expenses…

Wednesday Aug 07, 2024 - 2:16 pm

InvestorNewsBreaks – SideChannel Inc. (SDCH) Releases Quarterly Report, Notes Second Consecutive Quarter of Positive Cash Flow

SideChannel (OTCQB: SDCH), a leading provider of cybersecurity services and technology to emerging and middle market companies, is reporting its financial results for the three- and nine-month period ended June 30, 2024. Highlights of the report include third-quarter revenue of $1.8 million, year-to-date revenue of $5.5 million, and third-quarter gross margin of 48.9%. The report also showed a decrease in third-quarter operating expenses. In addition, the…

Wednesday Aug 07, 2024 - 1:54 pm

InvestorNewsBreaks – Iteris Inc. (NASDAQ: ITI) Selected by City of Lakeland to Enhance Road User Safety, Security

Iteris (NASDAQ: ITI), the world’s trusted technology ecosystem for smart mobility infrastructure management, today announced that the City of Lakeland, Florida, has selected it to provide smart mobility infrastructure management technologies to support the city’s Intersection Crash Avoidance Safety Program (“iCASP”). The project includes the deployment of key components of Iteris’ ClearMobility(R) Platform, the world’s most complete solution to monitor, visualize and optimize mobility infrastructure…

Wednesday Aug 07, 2024 - 1:00 pm

InvestorNewsBreaks – Freight Technologies Inc.’s (NASDAQ: FRGT) Fr8App Integrates with Tecnomotum to Streamline Logistics Operations

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), an innovative logistics technology solutions company, today announced the integration of its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region, with Tecnomotum, one of the largest data transmission companies for haulage in Mexico. According to the announcement, this integration aims to…

Wednesday Aug 07, 2024 - 11:55 am

InvestorNewsBreaks — Trump Media & Technology Group (NASDAQ: DJT) Announces ‘Milestone’ Launch of TV Streaming on iOS Devices

Trump Media & Technology Group (NASDAQ: DJT), operator of the social-media platform Truth Social, has added linear TV streaming functionality on iOS devices. According to the announcement, iOS users can update their Truth Social apps through the Apple App Store to access TV streaming. After the app has been updated, they can use the new feature by clicking on the Truth+ streaming icon, which looks…

Wednesday Aug 07, 2024 - 11:30 am

InvestorNewsBreaks – Nature’s Miracle Holding Inc. (NASDAQ: NMHI) Closes on Public Offering Valued at $1.2M

Nature's Miracle (NASDAQ: NMHI), a growing agriculture-technology company providing equipment and services to growers in the controlled environment agriculture ("CEA") industry, has closed on its previously announced underwritten public offering. The offering was comprised of five million shares of common stock at a public offering price of $0.24 per share. The offering resulted in gross proceeds of $1.2 million, before underwriting discounts and offering expenses were deducted. The…

Wednesday Aug 07, 2024 - 11:23 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Promotes ‘Invaluable Asset’ to Position of President of Commercial EV Division

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced John Taylor as president of its commercial EV division. In his new role, Taylor will oversee the company’s commercial vehicle operations, including engineering, supply chain management and manufacturing. Taylor, who brings a great breath of experience with a career spanning more than 35 years, also retains his role as senior vice president of…

Wednesday Aug 07, 2024 - 11:01 am

InvestorNewsBreaks – Independence Contract Drilling Inc. (NYSE: ICD) Releases Q2 2024 Financial Results

Independence Contract Drilling (NYSE: ICD), a company that provides land-based contract drilling services for oil and natural-gas producers in the United States, is reporting its Q2 2024 financial results for the three-month period ended June 30, 2024. Notable numbers from the report include a net loss of $16.7 million, or $1.15 per share, with adjusted net loss of $10.6 million, or $0.73 per share. Adjusted EBITDA totaled $8.5 million, representing a 28%…

Wednesday Aug 07, 2024 - 11:00 am

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters Agreement to Launch New Study of SPU-16 Homing Peptide for Multiple Sclerosis

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on developing novel formulations and drug-delivery systems for traditional therapeutics and psychedelic treatments, has entered into an agreement with WuXi AppTec (Hong Kong) Limited, a leading global contract research organization (“CRO”). The agreement regards the launch of a preclinical small animal study of SPU-16, a central nervous system (“CNS”) homing peptide targeting multiple sclerosis (“MS”). According…

Wednesday Aug 07, 2024 - 10:54 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate in a Fireside Chat at Upcoming Conference

Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage biopharmaceutical company developing new and innovative next-generation psychedelic-based treatment options, today announced that its CEO, Doug Drysdale, will participate in a fireside chat at the Canaccord Genuity 44th Annual Growth Conference on Tuesday, August 13, 2024, at 2 p.m. ET. Mr. Drysdale’s fireside chat will be a live webcast. The archived webcast will be available on…

Wednesday Aug 07, 2024 - 10:25 am

InvestorNewsBreaks – Bebuzee Inc. (BBUZ) Announces ‘Milestone’ Launch of SuperApp Designed to Change Users’ Interaction with Digital Services

Bebuzee (OTC: BBUZ), a pioneering force in the realm of social technology, has unveiled a new SuperApp designed to transform the way users interact with technology. According to the announcement, the new app, which will be available Aug. 30, 2024, offers an extensive array of features in a single, seamless platform. Those features include video streaming, photo sharing, instant messaging, short-form videos, global real estate…

Wednesday Aug 07, 2024 - 10:07 am

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Schedules Release of Q2 2024 Financial Results, Conference Call

Predictive Oncology (NASDAQ: POAI) is a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (“CLIA”) laboratory and Good Manufacturing Practices (“GMP”) to accelerate oncology drug discovery and enable drug development. The company expects to report its financial results for the second quarter of fiscal 2024, ended June 30, 2024, before markets open on…

Wednesday Aug 07, 2024 - 9:54 am

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Releases Q2 2024 Financial Results, Provides Updates

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), today released its Q2 2024 financial results. In addition, the company provided recent updates on its CNM-Au8(R) programs evaluating the use of CNM-Au8…

Wednesday Aug 07, 2024 - 9:42 am

InvestorNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Release Promising Clinical Data As Global Alzheimer’s Disease Therapeutics Market Grows

Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), has released preclinical data from a study of its lead compound, buntanetap. According to the announcement, the study showed the synergistic effect of buntanetap combined with the glucagon-like peptide 1 (GLP-1) agonist dulaglutide (Trulicity[R]) in enhancing cognition in a mouse model of…

Tuesday Aug 06, 2024 - 2:09 pm

InvestorNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Tech, PureSecurity Suite Offers Tools to Address Growing Domestic Violence Concerns

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has noted that electronic monitoring (“EM”) technology is being utilized as a significant and accessible solution for preventing domestic violence. With that in mind, the company is interested in seeing the tools in its PureSecurity Suite used to protecting victims of domestic violence; the platform can…

Tuesday Aug 06, 2024 - 2:03 pm

InvestorNewsBreaks – Finovate Shares FinovateFall Agenda Highlights

Finovate, a research and events company focused on innovation in financial and banking technology, is hosting FinovateFall, a pioneering fintech conference focused on the digital future of financial institutions. The event is slated for Sept. 9–11, 2024, in New York City. According to the announcement, the three-day fintech conference is “by and for executives and thought leaders who are revolutionizing the financial services industry.” The…

Tuesday Aug 06, 2024 - 1:24 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases “Noteworthy” Weight-Loss Results from Recent Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting recent results from its WEIGHT-A24-1 animal study. A recent article notes that interim results, which are based on the first 28 days of dosing, are “noteworthy,” including all animals showing either a noticeable decrease in the rate of body weight gain or the beginning of weight reduction. According to the article, the…

Tuesday Aug 06, 2024 - 1:16 pm

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) JustCBD Brand Launches New Calm, Sleep Gummies

Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor, through its JustCBD brand, has unveiled two new products: JustCBD+ Calm Gaba & L-Theanine Mixed Berry Gummies and JustCBD+ Sleep Magnesium and Melatonin Raspberry Gummies. These new gummy products are formulated to support stress management, promote relaxation and enhance sleep quality. Specifically, the JustCBD+ Calm Gaba & L-Theanine Mixed Berry Gummies are renowned for…

Tuesday Aug 06, 2024 - 12:33 pm

InvestorNewsBreaks — Astiva Health Announces Launch of Investor Relations Website to Facilitate Transparent, Effective Communication

Astiva Health, a leader in innovative and culturally aware healthcare solutions, today announced the launch of its new Investor Relations website. The launch marks a significant step and milestone in the company’s journey towards becoming a public company. It emphasizes Astiva Health’s commitment to maintaining transparent and effective communication and building strong relationships with investors, stakeholders, and the broader financial community. The platform will offer…

Tuesday Aug 06, 2024 - 11:52 am

InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Schedules Release of Q1 2025 Results, Conference Call

Vistagen (NASDAQ: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, is announcing that it will host a conference call and webcast on Tuesday, August 13, 2024, at 2 p.m. PT (5 p.m. ET). During the call and webcast, the company will report results for the first quarter of its fiscal year 2025 ended June 30,…

Tuesday Aug 06, 2024 - 11:37 am

InvestorNewsBreaks — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Schedules Conference Call to Discuss Q2 2024 Results

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is announcing the date for its upcoming conference call and webcast. The call is slated to begin at 11 a.m. EDT on Aug. 8, 2024. During the call, management will discuss the company’s second-quarter 2024 financial results as well as project developments. The call will also…

Tuesday Aug 06, 2024 - 11:33 am

InvestorNewsBreaks – Blockchain Futurist Conference Plays Pivotal Role in Shaping the Future of Web3, Finance

Blockchain Futurist Conference is Canada’s largest and most high-profile Web3, blockchain and cryptocurrency event. Serving as an essential platform for ideas and collaboration, the conference has proven to be an important global gathering helping shape the future of Web3. This year’s event is scheduled for August 13-14, 2024, in Toronto, Canada; the event will run alongside ETHToronto and ETHWomen Hackathons, the largest web3 hackathons in…

Tuesday Aug 06, 2024 - 11:22 am

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Submits New CNM-Au8 Biomarker, Clinical Efficacy Data to FDA

Clene (NASDAQ: CLNN), a late-stage biopharmaceutical company focused on protecting mitochondrial health and neuronal function to treat neurodegenerative diseases, and its wholly owned subsidiary Clene Nanomedicine Inc., have submitted new data to the U.S. Food and Drug Administration (“FDA”). The data is regarding CNM-Au8(R) biomarker and clinical efficacy information, including post hoc analyses from two phase 2 clinical trials of CNM-Au8 for the treatment of ALS; the…

Tuesday Aug 06, 2024 - 11:12 am

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Reports on Clinical Data Showing Lead Compound Combined with GLP-1 Agonist Enhances Cognition

Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), is reporting preclinical data regarding its lead compound, buntanetap. According to the announcement, the results show the synergistic effect of buntanetap when combined with the glucagon-like peptide 1 (“GLP-1”) agonist dulaglutide (Trulicity[R]) in a mouse model of Alzheimer’s disease. Based on data…

Tuesday Aug 06, 2024 - 11:02 am

InvestorNewsBreaks — Nightfood Holdings Inc. (NGTF) Expands into Growing Food-Service Segment with Recent Acquisition

Nightfood Holdings (OTCQB: NGTF), a forward-thinking acquisition and development holding company, has built a reputation in the sleep-friendly snack market. Now the company is expanding beyond the nighttime snack category into a growing segment of the food-service industry through recent acquisitions designed to diversify operations and capitalize on an emerging market. According to the article, Nightfood signed a letter of intent (“LOI “) to acquire…

Tuesday Aug 06, 2024 - 10:09 am

InvestorNewsBreaks – Ocugen Inc. (NASDAQ: OCGN) Closes on $35M Public Offering

Ocugen (NASDAQ: OCGN), a biotechnology company focused on discovering, developing and commercializing novel gene and cell therapies and vaccines, has closed on its previously announced underwritten public offering. The offering was comprised of 30,434,783 shares of its common stock, with each share sold at $1.15 per share. The company is anticipated to receive an estimated $35 million in gross proceeds, before standard deductions and expenses…

Tuesday Aug 06, 2024 - 9:49 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Shares Update from CEO

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today provided an update from CEO and chairman David Michery. According to the update, the company believes it has a strong foundation for future growth in EV sales based on the value of its total assets and cash position. Mullen highlighted the $250 million in new financing commitments it has secured to accelerate its growth…

Tuesday Aug 06, 2024 - 9:37 am

InvestorNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Schedules Release of Q2 2024 Financial Results, Earnings Conference Call

Longeveron (NASDAQ: LGVN), a clinical-stage, regenerative-medicine biotechnology company developing cellular therapies for rare, life-threatening and chronic aging-related conditions, is planning to release its second-quarter 2024 financial report after markets close on Aug. 14, 2024. The company also announced that it has scheduled a conference call and webcast on the same day to discuss the report and provide a company update; the call will begin at…

Tuesday Aug 06, 2024 - 9:14 am

InvestorNewsBreaks – Snap Inc. (NYSE: SNAP) Faces Downturn Despite Revenue Growth

Snap (NYSE: SNAP), the parent company of Snapchat, faced a significant downturn in its stock value during after-hours trading following its second-quarter earnings report for 2024. Despite a 16% year-over-year increase in total revenue, reaching $1.24 billion, the decline in the company’s stock reflects investor concerns about Snap’s future growth prospects, especially given the deceleration from the 21% growth recorded in the first quarter of 2024. The mixed financial results…

Monday Aug 05, 2024 - 3:08 pm

InvestorNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Preparing for NDA Submission for Leading Drug Candidate

PaxMedica (OTC: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, is in the process of preparing to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”). The NDA is for PAX-101, an intravenous formulation of suramin that could potentially treat conditions such as Human African Trypanosomiasis and autism spectrum disorder (“ASD”). The process includes having a Type…

Monday Aug 05, 2024 - 2:40 pm

InvestorNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ) Focused on Building Framework to Strengthen Position in Growing Cannabis Sector

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), a leading entity in the cannabis and agricultural technology sectors, is focused on solidifying its position in the growing cannabis market. According to a recent article, the global cannabis market, which reached an estimated $27.7 billion in 2022, is forecast to total $82.3 billion in 2027. MedCana is working on becoming the world’s premier resource for pharmaceutical…

Monday Aug 05, 2024 - 1:10 pm

InvestorNewsBreaks — Energy and Water Development Corp. (EAWD) Offers Solution to Water Scarcity Amid Climate Change

Energy and Water Development (OTCQB: EAWD), a green-tech engineering solutions company focused on delivering water and energy to extreme environments, offers some independence from groundwater and other traditional sources for fresh water. That independence can make a difference within a framework created by existing issues associated with climate change and its impact on water access. A recent article notes that the company, which has experience…

Monday Aug 05, 2024 - 12:48 pm

InvestorNewsBreaks – ECGI Holdings Inc. (ECGI) Looking at Luxury Equestrian Market to Build Market Share

ECGI Holdings (OTC: ECGI), a diversified holding company focusing on viticulture, luxury fashion and equestrian markets, is eyeing segments of the luxury goods market as an opportunity to generate significant annual revenues. According to a recent article, ECGI believes the luxury apparel and accessories segments, which excludes broader categories such as watches, jewelry and beauty, make up about 50% of the luxury market in the…

InvestorNewsBreaks

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions